H.R. 2344
Referred to CommitteePrescription Drug Monitoring Act of 2021
Latest Action
Referred to the Subcommittee on Health.
4/2/2021 • House
Summary
Prescription Drug Monitoring Act of 2021
This bill imposes, as a condition on certain federal funding for the Prescription Drug Monitoring Program (PDMP), additional notification and reporting requirements concerning prescriptions for potentially addictive drugs.
States or territories that receive this funding must require
- prescribers to consult the PDMP before starting treatment with such drugs, and
- dispensers to report within 24 hours to the PDMP each time they fill a prescription for such drugs.
In addition, the state agency administering a PDMP must analyze reported data for patterns of prescription drug misuse or abuse and provide certain information to prescribers, law enforcement, the public, and other states and territories.
Introduced in House • 4/1/2021
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (2)
Party Breakdown
Sponsor
Cosponsors (1)
Bill Journey
Originated in the House
Introduced
April 1, 2021
Referred to the House Committee on Energy and Commerce.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law